Literature DB >> 1429581

Identification of xenin, a xenopsin-related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion.

G E Feurle1, G Hamscher, R Kusiek, H E Meyer, J W Metzger.   

Abstract

One of the peptides previously discovered in amphibians is the octapeptide xenopsin. As immunohistochemistry has also indicated the presence of xenopsin immunoreactivity in man, we extracted in the present investigation xenopsin-immunoreactive material from human gastric mucosa and purified it to homogeneity with several high performance liquid chromatography (HPLC) reverse phase and ion exchange chromatographic steps. The eluates were monitored with a radioimmunoassay for amphibian xenopsin. Determination of the amino acid sequence revealed a 25-amino acid peptide having 6 C-terminal amino acids in common with amphibian xenopsin. The sequence of this peptide, termed xenin 25, is M-L-T-K-F-E-T-K-S-A-R-V-K-G-L-S-F-H-P-K-R-P-W-I-L. The peptide was custom-synthesized. Mass spectrometry of the synthetic and the extracted peptide revealed identical molecular mass. Purification of 250 ml of human postprandial plasma with Sep-Pak C18 cartridges, reverse phase HPLC, and ion exchange chromatography demonstrated circulating xenin immunoreactivity at a retention time identical to xenin 25. The amount of xenin immunoreactivity at the position of xenin 25 on C18-HPLC increased significantly after a meal. A radioimmunoassay utilizing antibodies to xenin 25 and a 125I-labeled analogue of xenin 25 was used to measure immunoreactive xenin in the plasma of 10 volunteers. There was a significant rise of xenin immunoreactivity in the plasma after a meal. Intravenous infusion of the synthetic peptide in dogs stimulated exocrine pancreatic secretion beginning at a dose of 4 pmol/kg/min. The maximal effect was seen with 64 pmol/kg/min. We have detected, therefore, a new peptide, xenin 25, in human gastric mucosa; we have provided evidence for the presence of this peptide in the human circulation, and have shown a rise of plasma xenin concentrations after a meal. This peptide stimulates exocrine pancreatic secretion. Its physiologic role deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429581

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.

Authors:  Sara Chowdhury; Dominic N Reeds; Dan L Crimmins; Bruce W Patterson; Erin Laciny; Songyan Wang; Hung D Tran; Terry A Griest; David A Rometo; Judit Dunai; Michael J Wallendorf; Jack H Ladenson; Kenneth S Polonsky; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

Review 2.  The migrating motor complex: control mechanisms and its role in health and disease.

Authors:  Eveline Deloose; Pieter Janssen; Inge Depoortere; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

3.  Xenin Augments Duodenal Anion Secretion via Activation of Afferent Neural Pathways.

Authors:  Izumi Kaji; Yasutada Akiba; Ikuo Kato; Koji Maruta; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  J Pharmacol Exp Ther       Date:  2017-01-23       Impact factor: 4.030

4.  Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet.

Authors:  Matthew C Althage; Eric L Ford; Songyan Wang; Patrick Tso; Kenneth S Polonsky; Burton M Wice
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

5.  Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents.

Authors:  N Arslan; O Sayin; Y Tokgoz
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

6.  Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Authors:  J Mazella; J M Botto; E Guillemare; T Coppola; P Sarret; J P Vincent
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

7.  Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.

Authors:  Karin Sterl; Songyan Wang; Lauren Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Peptides       Date:  2016-06-07       Impact factor: 3.750

8.  Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.

Authors:  Sheng Zhang; Krzysztof Hyrc; Songyan Wang; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-18       Impact factor: 4.052

9.  Xenin: the oldest after insulin?

Authors:  Alexander T Maryanovich; Dmitry Yu Kormilets; Andrey D Polyanovsky
Journal:  Mol Biol Rep       Date:  2018-01-16       Impact factor: 2.316

10.  Neurotensin and its receptors in the control of glucose homeostasis.

Authors:  Jean Mazella; Sophie Béraud-Dufour; Christelle Devader; Fabienne Massa; Thierry Coppola
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.